PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells

• Shuhei Ito,

  Affiliations Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan

  ⨯
• Conleth G. Murphy,

  Current address: Department of Medical Oncology, Bon Secours Hospital, Cork, Ireland

  Affiliation Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Ekaterina Doubrovina,

  Affiliation Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Maria Jasin,

  Affiliation Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Mary Ellen Moynahan

  * E-mail: moynaham@mskcc.org

  Affiliation Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯